Healthcare -
Biotechnology - NASDAQ - US
$ 6.47
-0.919 %
$ 277 M
Market Cap
-11.55
P/E
DMAC - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities DMAC - DiaMedica Therapeutics Inc.
-18.3 M
LAST VALUE
5.61%
2 YEAR CAGR
-225.61%
5 YEAR CAGR
-63.47%
10 YEAR CAGR